Abstract
In breast cancer, interruption of estrogen receptor (ER)-α function is an effective therapeutic strategy. Despite the clinical benefit of interruption of ER-α function, the precise biological action of ER-α in breast tumors is not completely understood. Results of a recent study show that ER-α promotes growth of breast cancer cells by targeting expression of signaling components of the insulin-like growth factor system. Intriguingly, the authors of this study raise the possibility that unliganded ER-α itself may affect gene expression and breast cancer biology, and they suggest a potential mechanism for ER-α to stimulate proliferation in breast cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 62-64 |
Number of pages | 3 |
Journal | Breast Cancer Research |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - 2002 |
Keywords
- Breast cancer
- Estrogen receptor
- Insulin-like growth factors